Skip to content

Checked

Class IIIDrug recallTerminated

PYRIDOXINE HCL recall

Recalled by Medaus, Inc. of Birmingham, AL · FDA report 07/20/2016

Not an official recall notice and may be delayed. Confirm with the manufacturer or the agency.

Class
Class III
Low risk
Status
Terminated
Closed 06/16/2017
Recall started
05/13/2016
Distribution
Nationwide

Reason for recall

Lack of Assurance of Sterility

Class III: Use of or exposure to the product is not likely to cause adverse health consequences.

Recalled product

Product
PYRIDOXINE HCL 100MG/ML W/PRES (BENZYL ETOH 0.02%), 5ML Vials, MEDAUS PHARMACY
Lot and code info
Lot #: 151220-6, BUD: 06/17/16, Lot #: 160225-7, BUD: 08/23/16
Quantity
4000 mL in Vials
Recall number
D-1236-2016
Event ID
74466
Initiated by
Voluntary: Firm initiated

Where it was distributed

U.S. Nationwide, Japan, and New Zealand.

  • Nationwide

Recall timeline

  1. 05/13/2016Firm started the recall
  2. 07/08/2016FDA classified it as Class III
  3. 07/20/2016Published in the FDA enforcement report
  4. 06/16/2017FDA closed (terminated) the recall

All products in this recall

88 products under event 74466

More recalls from Medaus

Frequently asked questions

Why was PYRIDOXINE HCL recalled?
Lack of Assurance of Sterility
What does Class III mean?
Class III is FDA's low risk recall category: use of or exposure to the product is not likely to cause adverse health consequences.
Where was the recalled product sold?
U.S. Nationwide, Japan, and New Zealand.
Is this recall still active?
The FDA lists the recall as terminated (closed 06/16/2017). FDA has determined the recall is complete and closed it.

Source: U.S. Food and Drug Administration, openFDA enforcement report · Last updated 07/20/2016 · Do not rely on openFDA to make decisions regarding medical care